Piperidin-4-yl(thiophen-2-yl)methanone

Catalog No.: 
ACWARF472
CAS No.: 
86542-98-5
Molecular Formula: 
C10H13NOS
Molecular Weight: 
195.29
Piperidin-4-yl(thiophen-2-yl)methanone structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$394.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NamePiperidin-4-yl(thiophen-2-yl)methanone
IUPAC Namepiperidin-4-yl(thiophen-2-yl)methanone
MDL No.MFCD09807612
Molecular FormulaC10H13NOS
Molecular Weight195.29
SMILESO=C(C1CCNCC1)C1=CC=CS1
InChI KeyQBJGQECJNLNPLJ-UHFFFAOYSA-N
Synonym4-Piperidinyl(2-thienyl)methanone;4-[(thiophen-2-yl)carbonyl]piperidine;4-(thiophene-2-carbonyl)piperidine;piperidin-4-yl(thiophen-2-yl)methanone;Methanone, 4-piperidinyl-2-thienyl-
CAS No.86542-98-5

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACWARF472 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. ACBAUS147 route compound structure diagram
    ACBAUS1472923-16-2In Stock
  6. Then
  7. ACWARF472 route product structure diagram
    ACWARF47286542-98-5
Inquiry

2. ACWARF472 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWARF472 route product structure diagram
    ACWARF47286542-98-5
Inquiry

3. ACWARF472 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWARF472 route product structure diagram
    ACWARF47286542-98-5
Inquiry

Comments (0)